brivanib Search Results


brivanib  (MedChemExpress)
94
MedChemExpress brivanib
Antiviral activity against EV-A71, cytotoxicity, and selectivity index
Brivanib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib/product/MedChemExpress
Average 94 stars, based on 1 article reviews
brivanib - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier
pi 103  (Selleck Chemicals)
92
Selleck Chemicals pi 103
Antiviral activity against EV-A71, cytotoxicity, and selectivity index
Pi 103, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pi 103/product/Selleck Chemicals
Average 92 stars, based on 1 article reviews
pi 103 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
brivanib  (TargetMol)
91
TargetMol brivanib
a Huh7 cells were treated with 10 <t>μM</t> <t>lenvatinib</t> or <t>brivanib</t> with or without glucose. ns, no significant difference. b , c HCC cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. Cell death was determined by subG1 ( b ) and LDH release assays ( c ). d Huh7 cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in glucose-free medium before detection of cellular ATP contents. e Huh7 cells were pretreated with bafilomycin A1 (50 nM) for 30 min before treatment with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. * P < 0.05; *** P < 0.001.
Brivanib, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib/product/TargetMol
Average 91 stars, based on 1 article reviews
brivanib - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier
brivanib alaninate bms-582664  (Fisher Scientific)
90
Fisher Scientific brivanib alaninate bms-582664
a Huh7 cells were treated with 10 <t>μM</t> <t>lenvatinib</t> or <t>brivanib</t> with or without glucose. ns, no significant difference. b , c HCC cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. Cell death was determined by subG1 ( b ) and LDH release assays ( c ). d Huh7 cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in glucose-free medium before detection of cellular ATP contents. e Huh7 cells were pretreated with bafilomycin A1 (50 nM) for 30 min before treatment with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. * P < 0.05; *** P < 0.001.
Brivanib Alaninate Bms 582664, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib alaninate bms-582664/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
brivanib alaninate bms-582664 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib bms582664  (Bristol Myers)
90
Bristol Myers brivanib bms582664
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib Bms582664, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib bms582664/product/Bristol Myers
Average 90 stars, based on 1 article reviews
brivanib bms582664 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib  (Bristol Myers)
90
Bristol Myers brivanib
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib/product/Bristol Myers
Average 90 stars, based on 1 article reviews
brivanib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib zl-2301  (ZAI Lab)
90
ZAI Lab brivanib zl-2301
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib Zl 2301, supplied by ZAI Lab, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib zl-2301/product/ZAI Lab
Average 90 stars, based on 1 article reviews
brivanib zl-2301 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib alaninate  (Galbraith Laboratories Inc)
90
Galbraith Laboratories Inc brivanib alaninate
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib Alaninate, supplied by Galbraith Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib alaninate/product/Galbraith Laboratories Inc
Average 90 stars, based on 1 article reviews
brivanib alaninate - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals brivanib
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib/product/MultiTarget Pharmaceuticals
Average 90 stars, based on 1 article reviews
brivanib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib alaninate  (ApexBio)
90
ApexBio brivanib alaninate
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib Alaninate, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib alaninate/product/ApexBio
Average 90 stars, based on 1 article reviews
brivanib alaninate - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib  (ChemPartner)
90
ChemPartner brivanib
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib, supplied by ChemPartner, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib/product/ChemPartner
Average 90 stars, based on 1 article reviews
brivanib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
brivanib  (Adooq Bioscience LLC)
90
Adooq Bioscience LLC brivanib
Selected FGFR inhibitors currently used in clinical development and/or evaluation
Brivanib, supplied by Adooq Bioscience LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brivanib/product/Adooq Bioscience LLC
Average 90 stars, based on 1 article reviews
brivanib - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Antiviral activity against EV-A71, cytotoxicity, and selectivity index

Journal: Journal of Virology

Article Title: Vascular endothelial growth factor receptor 2 as a potential host target for the inhibition of enterovirus replication

doi: 10.1128/jvi.01129-24

Figure Lengend Snippet: Antiviral activity against EV-A71, cytotoxicity, and selectivity index

Article Snippet: Pirodavir (CAS No. 124436–59-5), Pazopanib (CAS No. 444731–52-6), Brivanib (CAS No. 649735–46-6), SU14813 (CAS No. 627908–92-3), Axitinib (CAS No. 319460–85-0), and Dasatinib (CAS No. 302962–49-8) were all purchased from MedChemExpress.

Techniques: Activity Assay

a Huh7 cells were treated with 10 μM lenvatinib or brivanib with or without glucose. ns, no significant difference. b , c HCC cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. Cell death was determined by subG1 ( b ) and LDH release assays ( c ). d Huh7 cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in glucose-free medium before detection of cellular ATP contents. e Huh7 cells were pretreated with bafilomycin A1 (50 nM) for 30 min before treatment with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. * P < 0.05; *** P < 0.001.

Journal: Experimental & Molecular Medicine

Article Title: Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy

doi: 10.1038/s12276-022-00878-x

Figure Lengend Snippet: a Huh7 cells were treated with 10 μM lenvatinib or brivanib with or without glucose. ns, no significant difference. b , c HCC cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. Cell death was determined by subG1 ( b ) and LDH release assays ( c ). d Huh7 cells were treated with cisplatin (220 μM) or doxorubicin (2 μg/ml) in glucose-free medium before detection of cellular ATP contents. e Huh7 cells were pretreated with bafilomycin A1 (50 nM) for 30 min before treatment with cisplatin (220 μM) or doxorubicin (2 μg/ml) in the glucose-free medium. * P < 0.05; *** P < 0.001.

Article Snippet: Sorafenib (#T0093L) was purchased from TargetMol (Shanghai, China); lenvatinib (#S1164), brivanib (#S1084) and bafilomycin A1 (#S1413) were purchased from Selleck (Shanghai, China); cisplatin (#P4394), doxorubicin (#D1515), N -acetyl- l -cysteine (NAC, #A7250), and Hoechst (#94403) were purchased from Sigma‒Aldrich (Shanghai, China); canagliflozin (#A11100) was purchased from AdooQ Bioscience (Nanjing, China); and oligomycin (#HY-N6782), antimycin A (#HY-105755), phloretin (#HY-N0142), z-VAD-FMK (#HY-16658B), necrostatin-1 (#HY-15760), and ferrostatin-1 (#HY-100579) were purchased from MedChemExpress (Shanghai, China).

Techniques:

Selected FGFR inhibitors currently used in clinical development and/or evaluation

Journal: Translational Lung Cancer Research

Article Title: Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

doi: 10.3978/j.issn.2218-6751.2013.03.05

Figure Lengend Snippet: Selected FGFR inhibitors currently used in clinical development and/or evaluation

Article Snippet: Brivanib (BMS582664) , Bristol Myers Squib , VEGFRs and FGFRs , II.

Techniques: